EMBRN history

From a European PhD training project in 2004 to a registered non-profit with around 300 members worldwide.

How the network began

The European Mast Cell and Basophil Research Network arose from a Marie Curie Early Stage Training (EST)–sponsored, multi-partner project on Mast Cells and Chronic Inflammatory Diseases (MCCID), initiated in 2004 and chaired by Ulrich Blank, Paris. Its aim was to foster PhD student training through networking and collaboration, with a focus on fundamental studies of mast cells in inflammatory diseases affecting various organs and tissues.

In July 2008, the fifth and final MCCID meeting at the University of Hohenheim led directly into a founding meeting for a European Mast Cell Research Network. The committee then concluded that basophils, cells closely related to mast cells, should be included – and the European Mast Cell and Basophil Research Network was formed.

Its primary goal is to support fundamental and clinical research and the training of young researchers, to better understand the physiological and pathological functions of mast cells and basophils and to improve treatment options for patients with mast cell- and basophil-driven diseases.

A special highlight of the early years was an interdisciplinary meeting in Paris in 2006, where all participants became mast cell fans for a day following the inspiring lecture of the late Prof. Marcus Maurer, who became one of the network’s most fervent supporters.

The eight founding laboratories

Partner Lead Institution Focus
1 Ulrich Blank (coordinator) CNRS/Inserm, Paris, France Mast cells in kidney diseases
2 Santa Ono University College London, UK Mast cells in eye diseases
3 Stephan Bischoff University of Hohenheim, Germany Mast cells in chronic inflammatory diseases of the gut
4 Ilkka Harvima University of Eastern Finland, Kuopio, Finland Mast cells in skin diseases
5 Gunnar Nilsson Karolinska Institutet, Stockholm, Sweden Mast cells in lung diseases
6 Gunnar Pejler Swedish University of Agricultural Sciences, Uppsala, Sweden Mast cell proteases in chronic inflammatory diseases
7 G. Zabucchi University of Trieste, Italy Electron microscopy of mast cells in chronic inflammation
8 Petri Kovanen University of Helsinki, Finland Mast cells in heart disease

Milestones

  1. Chaired by Ulrich Blank, Paris. Yearly meetings follow in Paris, Stockholm, Helsinki, Trieste and Hohenheim.

  2. Stephan Bischoff becomes the first president of the new European network.

  3. Founding session by conference call with Stephan C. Bischoff, Ulrich Blank, Franco H. Falcone, Francesca Levi-Schaffer, Axel Lorentz, Marcus Maurer, Gunnar Nilsson and Julia Trosien.

  4. From now on, the General Assembly elects the council.

  5. Since 26–27 November 2012, a legally recognised non-profit organisation under German and European law.

  6. Members can also join the International Eosinophil Society.

  7. Stephen J. Galli is elected Honorary Member.

Previous meetings

First held every year, the EMBRN meeting now takes place every two years together with the General Assembly.

Date City Meeting
July 2008 Stuttgart Meeting on forming the network
August 2009 Stuttgart Founding meeting of EMBRN
Dec 2010 Berlin 2nd EMBRN meeting
Nov 2011 Southampton 3rd EMBRN meeting
Nov 2012 Berlin 4th EMBRN meeting
Aug 2013 Udine 5th EMBRN meeting
Dec 2014 Munich 6th EMBRN meeting
Oct 2015 Marseille 7th EMBRN meeting
May 2017 Prague 8th EMBRN meeting
June 2019 Uppsala 9th EMBRN meeting
July 2022 Utrecht 10th EMBRN meeting
May 2024 Toulouse 11th EMBRN meeting
June 2026 Vienna 12th EMBRN meeting

Previous council members

The first official General Assembly was held in Southampton on 25 November 2011. Since then, the General Assembly has elected the following board members. Current terms in bold.

TermNameCity
President
2011–2015 Stephan C. Bischoff Stuttgart, Germany
2015–2019 Marcus Maurer Berlin, Germany
2019–2024 Francesca Levi-Schaffer Jerusalem, Israel
2024–2028 Gunnar Nilsson (current term) Stockholm, Sweden
Vice-president
2011–2013 Francesca Levi-Schaffer Jerusalem, Israel
2013–2022 Bernhard F. Gibbs Kent, UK
2022–2030 Nicolas Charles (current term) Paris, France
Secretary
2011–2015 Gunnar Nilsson Stockholm, Sweden
2015–2024 Jenny Hallgren Martinsson Uppsala, Sweden
2024–2028 Anne Dudeck (current term) Magdeburg, Germany
Treasurer
2011–2019 Axel Lorentz Stuttgart, Germany
2019–2028 Frank Siebenhaar (current term) Berlin, Germany
TermNameCity
Communication officer
2011–2015 Ulrich Blank Paris, France
2015–2024 Joana Vitte Marseille, France
2024–2028 Anna Di Nardo (current term) Rome, Italy / San Diego, USA
Corporate sponsor liaison officer
2011–2013 Marcus Maurer Berlin, Germany
2013–2021 Frank Redegeld Utrecht, Netherlands
2022–2024 Maud Hermans Rotterdam, Netherlands
2024–2030 Hanneke Oude Elberink (current term) Groningen, Netherlands
Scientific coordination officer
2011–2015 Franco H. Falcone Nottingham, UK
2015–2022 Carlo Pucillo Udine, Italy
2022–2030 Adrian M. Piliponsky (current term) Seattle, USA
Junior member liaison officer
2011–2013 Julia Trosien Berlin, Germany
2013–2017 Sheli Friedman Jerusalem, Israel
2017–2021 Miroslava Kardosova Prague, Czech Republic
2022–2026 Moise Michel Nîmes, France
2026–2030 Jelle Folkerts (current term) Bern, Switzerland

Our partners

International Eosinophil Society (IES) European Centre for Allergy Research Foundation (ECARF) DFG Priority Programme SPP 1394 “Mast cells” European Academy of Allergy and Clinical Immunology (EAACI) European Competence Network on Mastocytosis (ECNM) European Histamine Research Society (EHRS) European Cooperation in Science and Technology (COST) Global Allergy and Asthma Excellence Network (GA²LEN)

Your help is appreciated!

If you want to support our activities by donation or if you want to become a sponsor of EMBRN, please contact us.